Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 44.49 USD 1.25% Market Closed
Market Cap: 904.9m USD

Intrinsic Value

The intrinsic value of one NKTR stock under the Base Case scenario is hidden USD. Compared to the current market price of 44.49 USD, Nektar Therapeutics is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

NKTR Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Nektar Therapeutics

Intrinsic Value History
Dive into the past to invest in the future

NKTR looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether NKTR usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about NKTR?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NKTR valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Nektar Therapeutics.

Explain Valuation
Compare NKTR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NKTR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nektar Therapeutics

Current Assets 281.4m
Cash & Short-Term Investments 270.2m
Receivables 1.3m
Other Current Assets 9.9m
Non-Current Assets 20m
Long-Term Investments 4.8m
PP&E 10m
Other Non-Current Assets 5.2m
Current Liabilities 66.3m
Accounts Payable 15.6m
Accrued Liabilities 50.8m
Non-Current Liabilities 149.9m
Other Non-Current Liabilities 149.9m
Efficiency

Free Cash Flow Analysis
Nektar Therapeutics

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Nektar Therapeutics

Revenue
62.6m USD
Cost of Revenue
-8m USD
Gross Profit
54.6m USD
Operating Expenses
-191m USD
Operating Income
-136.4m USD
Other Expenses
15.6m USD
Net Income
-120.7m USD
Fundamental Scores

NKTR Profitability Score
Profitability Due Diligence

Nektar Therapeutics's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Net Margin is Increasing
hidden
Profitability
Score

Nektar Therapeutics's profitability score is hidden . The higher the profitability score, the more profitable the company is.

NKTR Solvency Score
Solvency Due Diligence

Nektar Therapeutics's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Nektar Therapeutics's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NKTR Price Targets Summary
Nektar Therapeutics

Wall Street analysts forecast NKTR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NKTR is 116.72 USD with a low forecast of 103.02 USD and a high forecast of 141.75 USD.

Lowest
Price Target
103.02 USD
132% Upside
Average
Price Target
116.72 USD
162% Upside
Highest
Price Target
141.75 USD
219% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NKTR is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

NKTR Insider Trading
Buy and sell transactions by insiders

NKTR News

What is the Intrinsic Value of one NKTR stock?

The intrinsic value of one NKTR stock under the Base Case scenario is hidden USD.

Is NKTR stock undervalued or overvalued?

Compared to the current market price of 44.49 USD, Nektar Therapeutics is hidden .

Back to Top